+ Follow us On Google

India’s Contract Research, Development, and Manufacturing Organisation (CRDMO) sector is in a sustained growth phase, supported by consistent global contract wins, new client additions, and expanding manufacturing capacities. The adoption of advanced technologies is boosting operational capabilities and driving valuation re-ratings across the industry.

Key domestic players such as Divi’s Labs, Anthem Biosciences, Sai Life Sciences, Piramal Pharma, and Neuland Labs are witnessing strong project inflows across both small-molecule and complex chemistry domains, reflecting deeper engagement from global innovators seeking high-quality, cost-efficient outsourcing partners with strong regulatory track records.

The industry’s evolution from pure API manufacturing to full

See Full Page